Lucy E. Wilson

Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023.

Anne K Chipman, D. Beiser, S. Eucker, 2023, Vaccine.